SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-16-009519
Filing Date
2016-11-07
Accepted
2016-11-07 16:21:43
Documents
74
Period of Report
2016-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q irwd-20160930x10q.htm 10-Q 2405380
2 EX-31.1 irwd-20160930ex3116835e5.htm EX-31.1 18750
3 EX-31.2 irwd-20160930ex3123ac30a.htm EX-31.2 18699
4 EX-32.1 irwd-20160930ex3211514d0.htm EX-32.1 8536
5 EX-32.2 irwd-20160930ex322b82cd5.htm EX-32.2 8672
  Complete submission text file 0001558370-16-009519.txt   10151008

Data Files

Seq Description Document Type Size
6 EX-101.INS irwd-20160930.xml EX-101.INS 2350488
7 EX-101.SCH irwd-20160930.xsd EX-101.SCH 65408
8 EX-101.CAL irwd-20160930_cal.xml EX-101.CAL 79296
9 EX-101.DEF irwd-20160930_def.xml EX-101.DEF 366274
10 EX-101.LAB irwd-20160930_lab.xml EX-101.LAB 632901
11 EX-101.PRE irwd-20160930_pre.xml EX-101.PRE 530053
Mailing Address 301 BINNEY STREET CAMBRIDGE MA 02142
Business Address 301 BINNEY STREET CAMBRIDGE MA 02142 617-621-7722
IRONWOOD PHARMACEUTICALS INC (Filer) CIK: 0001446847 (see all company filings)

IRS No.: 043404176 | State of Incorp.: DE
Type: 10-Q | Act: 34 | File No.: 001-34620 | Film No.: 161978389
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences